YOURmeds for medication support in long-term conditions (MIB289)Product type:AdviceProgramme:Medtech innovation briefingLast updated: 9 June 2023Published: 15 March 2022
Reversal of the anticoagulant effect of dabigatran: idarucizumab (ESNM73)Product type:AdviceProgramme:Evidence summaryPublished: 24 May 2016
AccuVein AV400 for vein visualisation (MIB6)Product type:AdviceProgramme:Medtech innovation briefingPublished: 23 June 2014